Gilead Sciences, Inc. (GILD), Wednesday announced that Merdad Parsey will step down from the role of Chief Medical Officer early next year.
The company added that it has initiated the search for a successor. Meanwhile, Parsey will continue the position till the first quarter of 2025.
Currently, Gilead Sciences' stock is trading at $73.06, up 1.98 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.